Vetoquinol - Universal Registration Document - 2021

2 28 Vetoquinol Universal Registration Document 2020 Financial report STATEMENT OF NON-FINANCIAL PERFORMANCE Our commitment to sustainable development In the context of an unprecedented health and economic crisis, the Vetoquinol laboratory had to confront several challenges and manage the direct and indirect impacts on our employees and our customers. Initially, we experienced a period of great uncertainty over the extent and consequences of the COVID-19 health crisis. This uncertainty caused us to be cautious and to focus on the safety of our employees at all our sites and in all our subsidiaries, as well as on our core mission: delivering our drugs to our customers, whether wholesalers or veterinary clinics. Thanks to the level-headedness and commitment of all our teams, the effective communication of health mea- sures, the establishment of a crisis unit and the rapid implementation of an adapted workstation structure, we were able to maintain our production at a good level of quality and quantity. In several countries, we had to implement reduced operations plans in our sales force, which could no longer visit our customers, in our Research and Development department and in certain support functions. Our work-at-home policies were tested and proven on a large scale. Our teams were ready with adapted tools that allowed them to work from home in safety. Subsequently, following a gradual lift of lockdown, we were faced with a twofold challenge: the resumption of our activities at a more normal pace and the integra- tion into our portfolio of the newly acquired Drontal ® and Profender ® product families in Europe. The results for the first half of the year showed that our strategy for managing the health crisis was the right one. The Veto- quinol laboratory is proud to have been able to reconcile employee safety with business continuity. This crisis brought all face-to-face events to a sudden halt and forced everyone to adapt to new ways of com- municating, meeting, training, sharing information, socializing and organizing work. By addressing not only the risks of contamination but also the risks of isola- tion of our employees, we managed to demonstrate our strong commitment to supporting and preserving the health and safety of our teams. The COVID-19 health crisis is neither over nor eradi- cated. The experience we have gained from managing this crisis, for both our employees and our customers, has enabled us to demonstrate our flexibility and our constant efforts to combine respect for the values we hold dear, the safety of our teams and the resilience of our business model. Matthieu Frechin Vetoquinol CEO